Evidence map›Paper›PMID 37208349›Full record

ArticleScientific data2023

FAIR in action - a flexible framework to guide FAIRification.

Danielle Welter, Nick Juty, Philippe Rocca-Serra, Fuqi Xu, David Henderson, Wei Gu, Jolanda Strubel, Robert T Giessmann, Ibrahim Emam, Yojana Gadiya and 13 more

Abstract read
In one paragraph

Article in Scientific data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. [FAIR health data in the national and international data space].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Danielle WelterLuxembourg Centre for Systems Biomedicine, ELIXIR Luxembourg, University of Luxembourg, L-4367, Belval, Luxembourg.ORCID 0000-0003-1058-2668
Nick JutyUniversity of Manchester, Department of Computer Science, The University of Manchester, Manchester, M13 9PL, UK.ORCID 0000-0002-2036-8350
Philippe Rocca-SerraOxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX13QG, Oxford, UK.ORCID 0000-0001-9853-5668
Fuqi XuEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, CB10 1SD, UK.ORCID 0000-0002-5923-3859
David HendersonBayer AG, Business Development & Licensing & OI, Muellerstrasse 178, 13353, Berlin, Germany.ORCID 0000-0002-6433-200X
Wei GuLuxembourg Centre for Systems Biomedicine, ELIXIR Luxembourg, University of Luxembourg, L-4367, Belval, Luxembourg.ORCID 0000-0003-3951-6680
Jolanda StrubelThe Hyve BV, Arthur van Schendelstraat 650, 3511 MJ, Utrecht, The Netherlands.ORCID 0000-0001-6675-4639
Robert T GiessmannBayer AG, Business Development & Licensing & OI, Muellerstrasse 178, 13353, Berlin, Germany.ORCID 0000-0002-0254-1500
Ibrahim EmamData Science Institute, Imperial College, London, UK.ORCID 0000-0002-7561-2787
Yojana GadiyaFraunhofer Institute for Translational Medicine and Pharmacology (ITMP) and Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), Schnackenburgallee 114, 22525 Hamburg, and Theodor Stern Kai 7, 60590, Frankfurt, Germany.ORCID 0000-0002-7683-0452
Tooba Abbassi-DaloiiDepartment of Bioinformatics (BiGCaT), NUTRIM, FHML, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-4904-3269
Ebtisam AlharbiCollege of Computer and Information Systems, Umm Al-Qura University, Mecca, Saudi Arabia.ORCID 0000-0002-3887-3857
Alasdair J G GrayDepartment of Computer Science, Heriot-Watt University, Edinburgh, EH14 4AS, Scotland, UK.ORCID 0000-0002-5711-4872
Melanie CourtotEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, CB10 1SD, UK.ORCID 0000-0002-9551-6370
Philip GribbonFraunhofer Institute for Translational Medicine and Pharmacology (ITMP) and Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), Schnackenburgallee 114, 22525 Hamburg, and Theodor Stern Kai 7, 60590, Frankfurt, Germany.ORCID 0000-0001-7655-2459
Vassilios IoannidisVital-IT Group, SIB Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland.ORCID 0000-0002-4209-2578
Dorothy S ReillyNovartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.ORCID 0000-0002-6677-3132
Nick LynchOpenPhacts Foundation, Cambridge, UK.ORCID 0000-0002-8997-5298
Jan-Willem BoitenFoundation Lygature, Utrecht, Netherlands.ORCID 0000-0003-0327-638X
Venkata SatagopamLuxembourg Centre for Systems Biomedicine, ELIXIR Luxembourg, University of Luxembourg, L-4367, Belval, Luxembourg.ORCID 0000-0002-6532-5880
Carole GobleUniversity of Manchester, Department of Computer Science, The University of Manchester, Manchester, M13 9PL, UK.ORCID 0000-0003-1219-2137
Susanna-Assunta SansoneOxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX13QG, Oxford, UK.ORCID 0000-0001-5306-5690
Tony BurdettEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, CB10 1SD, UK. tburdett@ebi.ac.uk.ORCID 0000-0002-2513-5396

Funding

Medical Research Council MR/V038966/1
6 · The paper itself

Abstract

The COVID-19 pandemic has highlighted the need for FAIR (Findable, Accessible, Interoperable, and Reusable) data more than any other scientific challenge to date. We developed a flexible, multi-level, domain-agnostic FAIRification framework, providing practical guidance to improve the FAIRness for both existing and future clinical and molecular datasets. We validated the framework in collaboration with several major public-private partnership projects, demonstrating and delivering improvements across all aspects of FAIR and across a variety of datasets and their contexts. We therefore managed to establish the reproducibility and far-reaching applicability of our approach to FAIRification tasks.

Indexed as

COVID-19Datasets as TopicHumansPandemicsPublic-Private Sector PartnershipsReproducibility of Results

Identifiers

PMID37208349
PMCPMC10199076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.